AstraZeneca begins advanced trials for COVID-19 antibody medication

AstraZeneca begins advanced trials for COVID-19 antibody
medication 1

(Natural News) British pharmaceutical company AstraZeneca has
commenced late-stage trials for its COVID-19 antibody drug. In�an
Oct. 9 statement, the company said that two tests for the AZD7442
long-acting antibody drug, involving 6,000 adult participants
worldwide, will look at the medication’s ability to prevent
COVID-19 symptoms. A subsequent trial to observe AZD7442’s use as
a…


Read More

Read the Full Article

Prepare Now Before its too Late

Discover where products are available & compare prices

Suicide spike in Japan linked to coronavirus pandemic; Prevention measures must be implemented immediately, experts warn
Study shows coronavirus protein can block pain, causing lack of symptoms in some

You might also like
Menu